Exclusive
Release Date
#44 Rethinking medical device safety, part 2 – Omar Aimer
Ask us anything about… disproportionality analysis!
#43 Rethinking medical device safety, part 1 – Omar Aimer
#42 Unpacking the WHO Global Smart Pharmacovigilance Strategy – Shanthi Pal
#41 How to use artificial intelligence in pharmacovigilance, part 2 – Niklas Norén